The cluster is too small relative to market cap and the CSBO sale is tied to option exercise (routine cash-out), not opportunistic selling. No bearish signal here. Continue to monitor next insider filings for any shift toward larger unplanned open-market sales by multiple C-suite members. The strong analyst consensus and institutional accumulation (Janus, BlackRock, Vanguard top holders) provide a counterweight.
Price Chart
Executive Summary
A cluster of insider sales at Maze Therapeutics involving the CEO ($622K) and the head of CSBO ($210K) for a total of $832K over a one-week window. The CEO's sale is an open-market disposition near the stock's highs, while the CSBO sale follows immediate derivative exercises — a classic cash-out pattern. At ~0.05% of market cap, the dollar value is trivial relative to the $1.6B valuation, and the historical calibration suggests past reads on MAZE have underperformed (25% win rate, -5.6% avg T+20). Combined with the CSBO sale matching option-exercise timing (likely routine vesting), the cluster lacks material predictive signal and warrants no bearish override.
Key Financial Metrics
Key Facts
- CEO Jason Coloma sold 23,925 shares for ~$622K (open-market sale).
- CSBO Atul Dandekar sold 7,500 shares for ~$210K on the same day he exercised options.
- Total cluster value $832K is ~0.05% of MAZE's $1.6B market cap.
- Dandekar's sale is a classic cashless-exercise pattern (exercise + immediate sale) — likely liquidity/vesting driven.
- Past model reads on MAZE have been heavily negative at T+20 (avg -5.58%, 25% win rate), suggesting neutral scoring avoids overstating signal.
- Analyst consensus is overwhelmingly bullish (92% buy, 0 sells).
Financial Impact
Total insider sales of $832K represent ~0.05% of market cap — below the materiality threshold.
Risk Factors
- CEO's unplanned open-market sale could be followed by more if the stock re-approaches recent highs.
- Historical model underperformance on MAZE (25% win rate, -5.6% avg T+20) cautions against overweighting this signal either way.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-MAZE-1782977730398 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 27d ago | Insider Cluster | $26.37 $24.23 | ▼ −8.12% | ▼ −7.00% | $26.69 (+1.20%) |
Sep 4, 2026 27d ago | Insider Cluster | $26.37 $24.23 | ▼ −8.12% | ▼ −7.00% | $26.69 (+1.20%) |
Sep 3, 2026 29d ago | Insider Cluster | $25.87 $24.60 | ▼ −4.91% | ▼ −3.76% | $26.69 (+3.16%) |
Sep 2, 2026 29d ago | 144 | $25.87 $24.60 | ▼ −4.91% | ▼ −3.76% | $26.69 (+3.16%) |
Sep 1, 2026 4w ago | 144 | $26.72 $24.82 | ▼ −7.11% | ▼ −6.15% | $26.69 (−0.12%) |
Aug 17, 2026 6w ago | 3 | $29.13 $30.42 | ▲ +4.43% | ▲ +4.63% | $26.69 (−8.38%) |
Aug 11, 2026 7w ago | Press Release | $27.53 $29.75 | ▲ +8.06% | ▲ +8.51% | $26.69 (−3.06%) |
Aug 7, 2026 8w ago | Institutional Cluster | $28.65 $27.18 | ▼ −5.13% | ▼ −5.53% | $26.69 (−6.85%) |
Aug 5, 2026 8w ago | Insider Cluster | $27.81 $27.53 | ▼ −1.01% | ▼ −1.36% | $26.69 (−4.04%) |
Jul 2, 2026 13w ago | Insider Cluster | $31.26 $32.42 | ▲ +3.71% | ▲ +2.78% | $26.69 (−14.63%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access